Zoe Diana Draelos, MD, Talks Cosmeceuticals at Fall Clinical

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

(Editor's Note): Zoe Diana Draelos, MD, is a research and clinical board-certified dermatologist and a Fellow of the American Academy of Dermatology. She is in solo private practice in High Point, North Carolina, and a consulting professor of Dermatology at Duke University School of Medicine. In 1988, she founded Dermatology Consulting Services, PLLC, to initiate and perform research in aging skin, acne, rosacea, psoriasis, atopic dermatitis, actinic keratoses, eczema, and aesthetic procedures in the cosmetic, OTC drugs, and pharmaceutical arenas. Prior to pursuing a medical career, Dr. Draelos completed an undergraduate degree in mechanical engineering and was elected a Rhodes Scholar. A member of Sigma Xi research honorary and Alpha Omega Alpha medical honorary, she is author of 14 books including Cosmetics in Dermatology, Hair Cosmetics and Cosmetic Dermatology: Products and Procedures, as well as the editor of Cosmeceuticals, now in its third edition and translated into 7 languages.

Transcript:

Hello, my name is Zoe Diana Draelos. I am a dermatologist and president of Dermatology Consulting Services [in High Point, North Carolina]. I'm also the medical editor for Dermatology Times. I'm really excited about the upcoming meeting in Las Vegas, Nevada, for Fall Clinical. I will be speaking there on an update on cosmeceuticals and what's new in cosmeceuticals. It's personalization of sunscreens: personalization of all kinds of sunscreens, sensitive skin sunscreens, anti-aging sunscreens, sunscreens with vehicles designed for the face of each individual person. But that's not all. Cosmeceuticals are also becoming personalized, how using your own skin tissue that's cultured and using your own fibroblast conditioned media. You now can make cosmeceuticals that have growth factors that are endogenous, that are autologous, that are yours. Furthermore, we're also seeing expanded uses of platelet-rich plasma. Again, slight growth factors being repositioned to the face from the serum. So personalization is really where it's at in cosmeceuticals, using things that work with your bodies, specifically with your DNA and your background. So I'm looking forward to sharing with everybody this lecture and I'm looking forward to seeing you at Fall Clinical. Thank you so much.